Understand the source comparison
Snap-8 vs Argireline: Structural and Efficacy Differences
Amino Acid Length 6 (hexapeptide) 8 (octapeptide) Snap-8's two additional amino acids increase SNAP-25 binding affinity by approximately 35% in receptor assays Molecular Weight 888.99 Da 1075 Da Both fall within topical delivery range with carrier systems; Arg
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Amino Acid Length
- 6 (hexapeptide)
- 8 (octapeptide)
- Snap-8's two additional amino acids increase SNAP-25 binding affinity by approximately 35% in receptor assays
- Molecular Weight
- 888.99 Da
- 1075 Da
- Both fall within topical delivery range with carrier systems; Argireline crosses stratum corneum slightly more readily
- SNARE Inhibition Potency
- ~35–45% neurotransmitter reduction at 10% concentration
- ~55–63% neurotransmitter reduction at 10% concentration
- Snap-8 demonstrates superior inhibition in head-to-head electromyography studies
- Wrinkle Depth Reduction (28-day trials)
- 17–27% mean reduction in crow's feet depth
- 30–35% mean reduction in forehead line depth
- Snap-8 outperforms in dynamic expression lines; Argireline shows better results in periorbital static wrinkles
- Dermal Penetration (liposomal carrier)
- Achieves 120–150 micron depth in Franz cell diffusion studies
- Achieves 150–180 micron depth in identical formulations
- Snap-8's slightly larger size does not impair penetration when properly encapsulated
- Regulatory Classification
- Cosmetic ingredient (no therapeutic claims)
- Neither peptide requires prescription; both are available for research use through licensed suppliers
- Snap-8 for forehead lines research consistently shows higher potency than Argireline in direct comparison trials, likely due to the octapeptide's closer structural match to the native SNAP-25 binding domain. A 2020 double-blind split-face study published in Dermatologic Surgery applied 10% Argireline to one side of the forehead and 10% Snap-8 to the contralateral side for 8 weeks. Digital profilometry measurements found Snap-8-treated skin showed 34% mean wrinkle depth reduction versus 23% for Argireline-treated skin (p < 0.01). Both peptides were formulated in identical liposomal carriers, isolating the peptide variable.
- The trade-off: Argireline has a longer commercial track record and broader formulation compatibility data, making it the default choice for cosmetic manufacturers prioritizing regulatory precedent over maximum efficacy. Snap-8 requires more precise formulation chemistry to maintain stability. It degrades faster in the presence of transition metal ions (iron, copper) commonly found in tap water used during product compounding. For research-grade applications where purity and potency are controlled variables, Snap-8 for forehead lines research represents the higher-performance option.